CERVIX CANCER
Clinical trials for CERVIX CANCER explained in plain language.
Never miss a new study
Get alerted when new CERVIX CANCER trials appear
Sign up with your email to follow new studies for CERVIX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for advanced cervical cancer shows early promise but trial halted
Disease control TerminatedThis study tested a combination of two drugs—toripalimab (an immunotherapy) and chidamide (a targeted therapy)—in women with advanced cervical cancer that had come back or spread. The goal was to see if the combo was safe and could shrink tumors. Only 5 women enrolled before the …
Matched conditions: CERVIX CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Immune booster combined with radiation shows promise for cervical cancer
Disease control TerminatedThis early-phase study tested adding the immune-boosting drug pembrolizumab to standard chemoradiation for people with locally advanced cervical cancer. The goal was to see if the combination was safe and could help the immune system fight cancer more effectively. Only one person…
Matched conditions: CERVIX CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Scans may predict radiation success in cervical cancer
Knowledge-focused TerminatedThis study tested whether MRI and PET scans could predict if cervical cancer would be controlled by radiation therapy. It included 9 people with stage I to IIIB cervical cancer. The study was stopped early, so results are limited.
Matched conditions: CERVIX CANCER
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 26, 2026 05:07 UTC